Jennifer Wong is a counsel in the New York office and a member of the firm’s Mergers & Acquisitions Practice.

Jennifer represents public and private companies in a range of transactions, including:

  • Domestic and cross-border buyouts
  • Mergers and acquisitions
  • Divestitures
  • Asset acquisitions
  • Tender offers
  • Joint ventures
  • Carve-outs
  • General corporate governance matters

Jennifer advises clients across a variety of industries, including financial services, telecommunications, and health care.

In addition to her corporate practice, Jennifer has been engaged in a variety of pro bono efforts, including matters related to advising not-for-profit organizations on formation, corporate governance, and related general corporate matters.

Prior to joining Latham, Jennifer was an associate at another leading international law firm.

Jennifer’s experience includes the following selected transactions:

M&A Transactions

  • CAC Group, a nationally recognized specialty and middle-market insurance brokerage firm, in its US$1.026 billion sale to The Baldwin Group
  • Ontario Teachers’ Pension Plan in its sale of a portion of its investment in BroadStreet Partners, a leading North American insurance brokerage company, to an investor group led by Ethos Capital, British Columbia Investment Management Corporation, and White Mountains Insurance Group, Ltd.
  • Bridge Investment Group in its US$1.5 billion stock-for-stock sale to Apollo
  • BBAI Holdings, the NYSE-listed provider of intelligence solutions, in its stock-for-stock acquisition of Pangiam
  • Swedish Orphan Biovitrum in its US$1.7 billion acquisition of CTI Biopharma
  • Thomson Reuters Corporation in its acquisition of CaseText, a legal technology provider
  • Extra Space Storage in its US$590 million acquisition of Storage Express
  • ironSource Ltd. in its US$11.1 billion deSPAC merger with Thoma Bravo Advantage
  • Syneos Health in its acquisition of Synteract, a full-service contract research organization focused on the rapidly growing emerging biopharma segment
  • Ligand Pharmaceutical Incorporated in its tender offer for all the outstanding shares of Pfenex Inc. for US$437.5 million in cash, plus one non-transferable contingent value right per share representing the right to receive a contingent payment of US$78 million in cash upon the achievement of a certain specified milestone
  • Ribbon Communications Inc. in the sale of its Kandy Communications business to American Virtual Cloud Technologies, Inc.
  • Sony Pictures Entertainment in its US$1.175 billion acquisition of the Crunchyroll business unit from AT&T

GP-Led Secondary Transactions

  • Graham Partners in multiple GP-led continuation fund transactions
  • Bridge Investment Group in connection with multi-asset GP-led continuation fund transaction
  • Lindsay Goldberg in connection with single asset GP-led continuation fund transaction
  • Searchlight Capital Partners in connection with single asset GP-led continuation fund transaction
  • Saw Mill Capital in connection with multi-asset GP-led continuation fund transaction
  • Boathouse Capital in connection with single asset GP-led continuation fund transaction
  • Assured Investment Management in multiple transactions, including in its sale of its interests in its portfolio of healthcare assets to its continuation fund
  • Partners Group in multiple continuation fund transactions in connection with its investment as lead investor
  • Ares in multiple continuation fund transactions in connection with its investment as lead investor

Bar Qualification

  • New York

Education

  • JD, University of Toronto Faculty of Law, 2013
  • Bachelor of Commerce, Queen's University, 2010
    with high honors